Drawing for QDOSE

USPTO serial 76140554

QDOSE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with QDOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gabrielle S. Roth

GABRIELLE S ROTH DICKSTEIN SHAPIRO MORIN & OSHINSKY LLP2101 L ST NWWASHINGTON, DC 20037-1526UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations in the nature of antiemetics, hepatoprotective pharmaceuticals, therapeutic anorectic drugs, therapeutic antiobesity drugs, antidiabetics, anabolic therapeutics, appetite stimulants, anticoagulants, antithrombotics, fibrinolytics, hemostatics, antianemics, coagulation factor treatments, antihypertensive therapies, fertility enhancers, reproductive treatments, gynecological treatments, anxiolytic therapies, neuroprotective pharmaceuticals, antidepressants, injections, antimigraine pharmaceuticals, and prophylactic and therapeutic vaccines; pharmaceutical preparations for treatment of septic shock, cardiovascular disease, allergic and inflammatory diseases, metabolic diseases, urological disease, cancer, pain, respiratory disease and disorders, neurological disease, immunological disease and osteoporosis; pharmaceutical preparations for the diagnosis of lung disease; and pharmaceutical preparations for drug dependence treatmentACTIVE—
010medical and surgical apparatus and instruments, namely inhalers, syringes, vials, needleless injectors, patches, and electronic and nasal pumps for pulmonary, oral, parenteral, nasal, transdermal and buccal methods of delivering drugs; parts and fittings for aforesaid goodsACTIVE—
042PHARMACEUTICAL RESEARCH AND DEVELOPMENT SERVICES; LICENSING OF INTELLECTUAL PROPERTY RIGHTSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 28, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 15, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2003ZZZYPREVIOUS ACTION COUNT WITHDRAWN—
Mar 10, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2002DOCKASSIGNED TO EXAMINER—
Apr 25, 2002MAILPAPER RECEIVED—
Mar 7, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 30, 2002DOCKASSIGNED TO EXAMINER—
Oct 26, 2001ZZZYPREVIOUS ACTION COUNT WITHDRAWN—
Oct 25, 2001DOCKASSIGNED TO EXAMINER—
Aug 22, 200144EASEC. 44(E) CLAIM ADDED—
Aug 22, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2001DOCKASSIGNED TO EXAMINER—
Feb 23, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance